Acadia Launches Parkinsonís Campaign to Shine Light on Psychosis Symptoms

Share

(December 1, 2017) - A new disease awareness campaign shines a light on the hallucinations and delusions that can affect half of people who have Parkinson’s disease. Sponsored by Acadia Pharmaceuticals, a TV ad and accompanying website focus on the common but lesser-known non-motor side effects of seeing and hearing things that aren’t real. Acadia is the only drugmaker with an approved treatment for the psychosis that can accompany Parkinson's. Read more

Click for a printer friendly version

Back to top